Abstract 3210: Neoadjuvant-adjuvant pembrolizumab (PEMBRO) in advanced basal cell carcinoma (BCC) induces memory-like T cell expansion with therapeutic promise
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Cleveland Clinic, Stanford Cancer Institute, Stanford University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409689411
